The therapeutic community is buzzing with anticipation surrounding retatrutide, a innovative dual GIP and GLP-1 receptor that’s showing significant efficacy in clinical trials for addressing obesity. Unlike some current weight loss treatments, retatrutide appears to deliver a significant substantial decrease in body size and benefit metabolic he… Read More